18F-Pentixafor PET in Hematologic Malignancies
- Conditions
- Hematological Malignancies
- Interventions
- Drug: 18F-Pentixafor
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- First Affiliated Hospital of Zhejiang University
- Target Recruit Count
- 100
- Registration Number
- NCT07122674
- Locations
- 🇨🇳
The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
2D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices
- Conditions
- Portal Hypertension Related to CirrhosisEsophageal Varices
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Target Recruit Count
- 450
- Registration Number
- NCT07122622
Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis
- Conditions
- PolymyositisDermatomyositis
- Interventions
- Biological: placebo
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Paean Biotechnology Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT07122648
- Locations
- 🇰🇷
Chung-Ang University Gwang Myeong Hospital, Gwangmyeong, Gyeonggi-do, Korea, Republic of
🇰🇷Kyung Hee University Medical Center, Seoul, Korea, Republic of
🇰🇷Seoul National University, Seoul, Korea, Republic of
Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons
- Conditions
- HIVHepatitis C Virus (HCV)
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Target Recruit Count
- 548
- Registration Number
- NCT07122219
- Locations
- 🇨🇦
Edmonton Institution for Women, Edmonton, Alberta, Canada
🇨🇦Fraser Valley Institution for Women, Abbotsford, British Columbia, Canada
🇨🇦Mission Institution, Mission, British Columbia, Canada
Post-Approval Study of PALMAZ MULLINS XD™ in Treating Pulmonary Artery Stenosis
- Conditions
- Pulmonary Artery Stenosis
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 75
- Registration Number
- NCT07122518
Feasibility and Safety of the Augmented Reality Guidance Software TAVIPILOT Software During Transcatheter Aortic Valve Replacement (TAVR/TAVI) in Australia
- Conditions
- TAVI(Transcatheter Aortic Valve Implantation)
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Caranx Medical
- Target Recruit Count
- 10
- Registration Number
- NCT07121907
Effect of Silymarin as Add on Therapy on Oxidative Stress, Pulmonary Function and Quality of Life in Stable COPD Patients.
- Conditions
- COPD (Chronic Obstructive Pulmonary Disease)
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- Target Recruit Count
- 70
- Registration Number
- NCT07123922
- Locations
- 🇧🇩
BSMMU, Dhaka, Bangladesh
Effect of Photobiomodulation on Healing of Venous Leg Ulcers: A Double-Blind Randomized Study
- Conditions
- Venous DiseaseVenous Insufficiency (Chronic)(Peripheral)Venous Leg Ulcer (VLU)Venous Leg UlcerVenous Insufficiency of LegVenous Hypertension UlcersVaricose UlcersVaricose Ulcer of Lower Limb
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- University of Nove de Julho
- Target Recruit Count
- 104
- Registration Number
- NCT07123285
- Locations
- 🇧🇷
Estratégia da Saúde da Família Monte Azul - "Antonio Benedetti"., Lençóis Paulista, São Paulo, Brazil
Impact of Diet-induced Change in Energy Balance on Metabolism in Endurance Athletes
- Conditions
- Energy BalanceLow Energy AvailabilityRelative Energy Deficiency in SportEnergy Deficit
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- University of Bath
- Target Recruit Count
- 20
- Registration Number
- NCT07122778
- Locations
- 🇬🇧
University of Bath, Bath, United Kingdom
Studies on Adsorption International Learning Initiative Global
- Conditions
- CKD (Chronic Kidney Disease) Stage 5DUremia; ChronicHemodialysisUremic; ToxemiaInflammation ChronicDialysis Related ComplicationInflammation BiomarkersAnemia Associated With End Stage Renal Disease
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Botkin Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT07123909
- Locations
- 🇷🇺
Botkin Hospital, Moscow, Russian Federation